FINWIRES · TerminalLIVE
FINWIRES

Research Alert: Edwards Lifesciences: Tavr Sales Expansion Drives Q1 Eps Beat

-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:

Edwards Lifesciences reported strong Q1 results with sales growing 16.7% Y/Y to $1.65B and adjusted EPS of $0.78, beating consensus estimates by $0.05. Operating margin expanded to 31.4% from 29.1% in the prior-year quarter, supported by $500M in quarterly share repurchases. The company benefits from momentum generated by EARLY TAVR study data driving earlier disease intervention, while Boston Scientific's European market exit strengthened EW's TAVR positioning, in our view. EW raised full-year 2026 guidance to 10% constant currency sales growth and $3.00 adjusted EPS midpoint, representing 17% growth vs. 2025. TAVR sales of $1.20B grew 14.4% Y/Y supported by SAPIEN growth globally, with raised guidance to 8% midpoint from 7% previously. TMTT sales surged 51.9% Y/Y driven by PASCAL adoption and higher EVOQUE utilization as procedure volumes rose in the double digits. We expect continued operating margin expansion toward the high end of EW's 28%-29% guidance range in 2026.

Related Articles

Research

Research Alert: CFRA Keeps Hold Opinion On Shares Of Eqt Corp.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Our 12-month target price remains $62, a combination of relative valuation and DCF models. On a relative basis, we apply a 6.2x multiple of enterprise value to projected 2027 EBITDA, above EQT's historical forward average. We think a small premium is defendable, given an improving operating cost profile. Our DCF model, using medium-term free cash flow growth of 4%, terminal growth of 2%, and WACC of 6.7%, yields a value of $70 per share. We lift our 2026 EPS estimate by $0.04 to $4.85 and 2027's by $0.01 to $4.68. Natural gas pricing has dissipated to a degree recently, leading EQT to pull back some production in Q2, but we still see modest volume growth in 2026. Longer-term growth drivers tied to data centers and liquefied natural gas export demand look intact, in our view. We think the most positive development is the improvement in free cash flow. Net debt levels are creeping closer to management's targeted levels.

$EQT
Australia

Unico Silver Reduces Rigs at Argentina Drilling Operations During Transition to Winter Operations

Unico Silver (ASX:USL) said it reduced the number of drill rigs under its drilling operations in Argentina to two from three as it moves into reduced winter operations, according to a Friday Australian bourse filing.The company plans to update the Joaquin project mineral resource estimate in the June quarter to incorporate recent infill drilling.In the same filing, the company said it is conducting pre-feasibility work streams, including geotechnical drilling and interpretation to define open-pit slope and design parameters, as well as comminution and metallurgical test work to confirm processing assumptions and recovery pathways.The company's shares fell past 1% in recent trading on Friday.

$ASX:USL
Asia

Japan Stocks Open Higher on Iran Talks, Lebanon Ceasefire Extension

Japanese shares slightly rose at the start of Friday's session, as investors remain cautiously optimistic on the U.S.-Iran negotiations after an extended ceasefire between Israel and Lebanon.The Nikkei 225 rose 267.2 points or 0.5% to open at 59,407.44President Donald Trump announced a three-week extension of the ceasefire between Israel and Lebanon, yet investors stayed wary as market direction depends on whether tensions with Iran intensify or move toward diplomatic solutions.The West Texas Intermediate climbed to about $97 a barrel, while Brent Crude closed at nearly $105 on Thursday.At home, Japan's core inflation accelerated to 1.8% in March from 1.6% the previous month, driven by higher energy costs-a trend that could affect the Bank of Japan's decision to leave its benchmark rate unchanged coming Tuesday.

$^N225